Skip to main content

Chris Wiley joined the atHeart Medical team as Vice-President for Field Operations and Therapy Development. He leads the American and European roll-out of our clinical trial program.

Chris has 20 years of field operations’ experience in structural heart devices from major corporations. He masters the complexities of multi-center clinical trial execution across geographies, understanding clinicians’ needs and delivering clinical support. He also trained as a radiologic technologist in the United States Air Force, where he specialized in cardiovascular interventions.

“Chris’ expertise in septal defects closure and his reputation among the medical community are phenomenal assets for our field operations,” said atHeart Medical’s CEO Laurent Grandidier. “We are very pleased to have him in a leading role for the seamless execution of our clinical trial program, as more patients requiring ASD closure are joining the ASCENT ASD trial.”

ASCENT ASD is a global multi-site clinical trial approved by US FDA, French ANSM, Health Canada and Swissmedic enrolling up to 250 patients in over 20 centers across two continents.

“atHeart Medical has the ambitious goal of improving the standards of care in atrial septal defects closure. I am very pleased to share my knowledge and expertise to serve this purpose,” said Chris.

View all team’s bios here